However, when considering progesterone receptor-negative breast cancer patients, and patients with other neoplasms, such as endometrial cancer, in which progestin has a protective effect,( 30 )the following question may be asked: why not use oral progestin in selected cases of cancer FP? The gene discussed is PGR; the disease is endometrial cancer.